Recombinant Xenopus laevis Insulin-like growth factor 1 receptor (igf1r)

What is the Xenopus laevis insulin-like growth factor 1 receptor (igf1r)?

Xenopus laevis igf1r is a receptor tyrosine kinase that mediates actions of insulin-like growth factor 1 (IGF1). This receptor binds IGF1 with high affinity and can also bind IGF2 and insulin with lower affinity. When activated, igf1r is involved in cell growth and survival control during embryonic development. The receptor is also known by alternative names including xIGF-1R, xIGFR, and XTK2 in various research publications .

What is the expression pattern of igf1r during Xenopus development?

Xenopus IRS-1 (Insulin Receptor Substrate-1), the major mediator of igf1r signaling, is expressed maternally and constantly throughout embryogenesis. Studies have shown that it is predominantly found in neural tissue at different developmental stages. This expression pattern suggests a critical role in neural development, particularly in eye formation where knockdown experiments have demonstrated significant developmental abnormalities .

What signaling pathways are activated by Xenopus igf1r?

Upon ligand binding, igf1r undergoes autophosphorylation, leading to the activation of multiple downstream signaling cascades. These include:

• The PI3K-AKT/PKB pathway, which inhibits apoptosis and stimulates protein synthesis

• The Ras-MAPK pathway, which increases cellular proliferation

• The JAK/STAT pathway, particularly STAT3 activation, which may be essential for the transforming activity of IGF1R

These pathways are activated through the phosphorylation of adaptor proteins including insulin-receptor substrates (IRS1/2), Shc, and 14-3-3 proteins .

How can recombinant Xenopus laevis igf1r be used in eye development research?

Recombinant Xenopus laevis igf1r can be utilized to investigate the molecular mechanisms of eye development through several approaches:

• Gain-of-function studies: Overexpression of recombinant igf1r in specific tissues to observe effects on eye formation and development

• Protein-protein interaction studies: Using purified recombinant protein to identify binding partners in eye development pathways

• Rescue experiments: Introduction of recombinant protein in igf1r-deficient embryos to restore normal eye development

• Signaling pathway analysis: Examining downstream effects of igf1r activation on eye-specific marker genes such as Rx1 and Pax6

What methods are most effective for studying igf1r knockdown effects in Xenopus?

For studying igf1r knockdown effects in Xenopus laevis, antisense morpholino oligonucleotides (MO) have proven particularly effective. Research has shown that specific MO targeting of IRS-1 in neural tissue resulted in abnormal eye formation accompanied by reduction of eye-specific marker genes Rx1 and Pax6 and decreased cell proliferation. For optimal results:

• Design morpholinos targeting the translation start site or splice junctions of igf1r mRNA

• Inject morpholinos at the 1-2 cell stage for ubiquitous knockdown

• Use targeted injections at the 8-16 cell stage for tissue-specific knockdown

• Include appropriate controls (such as mismatch morpholinos)

• Validate knockdown efficiency through Western blot or immunostaining

• Assess phenotypic consequences through molecular markers and morphological analysis

How do post-translational modifications affect Xenopus igf1r function?

Post-translational modifications of igf1r significantly impact its function in Xenopus development. The phosphorylation state of specific tyrosine residues (like Y1316 in human IGF1R) determines receptor activity and downstream signaling specificity. Key considerations for researchers include:

• Phosphorylation patterns dictate which downstream pathways are activated (PI3K-AKT vs. Ras-MAPK)

• Receptor autophosphorylation occurs at multiple tyrosine residues following ligand binding

• Different phosphorylation sites recruit distinct adaptor proteins

• Conservation of phosphorylation sites between Xenopus and mammalian IGF1R enables comparative studies

• Phospho-specific antibodies can be used to monitor activation status of the receptor in developmental contexts

What are the comparative differences between Xenopus laevis igf1r and mammalian IGF1R systems?

Understanding the differences between Xenopus and mammalian IGF1R systems is crucial for translational research. Key comparative aspects include:

Researchers should consider these differences when designing experiments and interpreting results across species .

What purification strategies yield the highest quality recombinant Xenopus igf1r?

To obtain high-quality recombinant Xenopus igf1r for experimental applications, researchers should consider the following purification strategies:

• Expression system selection:

  • E. coli systems for cytoplasmic domains

  • Baculovirus expression for full-length glycosylated receptor

  • Mammalian cell expression for properly folded receptor with post-translational modifications

• Affinity tag selection:

  • His-tag purification allows for single-step isolation

  • GST-fusion proteins for enhanced solubility

  • Dual tagging strategies for increased purity

• Purification considerations:

  • Include protease inhibitors throughout purification

  • Use phosphatase inhibitors to preserve phosphorylation states

  • Optimize buffer conditions to maintain protein stability

  • Validate purity by SDS-PAGE (≥85% purity standard)

• Functional validation:

  • Verify ligand binding capacity

  • Confirm kinase activity if applicable

  • Assess proper folding through circular dichroism

How can researchers effectively analyze igf1r-mediated signaling pathways in Xenopus models?

For comprehensive analysis of igf1r-mediated signaling in Xenopus models, researchers should implement a multi-faceted approach:

• Biochemical assays:

  • Western blotting with phospho-specific antibodies to detect activated downstream effectors

  • Immunoprecipitation to identify protein-protein interactions

  • Kinase activity assays to measure receptor functionality

• Genetic approaches:

  • Morpholino knockdown of igf1r or downstream components

  • mRNA overexpression of constitutively active or dominant negative forms

  • CRISPR/Cas9 genome editing for targeted mutations

• Cell biological techniques:

  • Immunohistochemistry to visualize spatial distribution of signaling components

  • BrdU incorporation assays to measure proliferation effects

  • TUNEL staining to assess apoptosis

• Transcriptional analysis:

  • RT-PCR or RNA-seq to identify changes in target gene expression

  • In situ hybridization to examine spatial expression patterns of downstream genes

  • ChIP assays to identify transcription factor binding to target promoters

How can researchers address non-specific effects when studying igf1r function in Xenopus?

When studying igf1r function in Xenopus, researchers often encounter non-specific effects that can confound experimental interpretation. Effective strategies to address these issues include:

• Specificity controls:

  • Use multiple morpholinos targeting different regions of igf1r mRNA

  • Include mismatch control morpholinos

  • Perform rescue experiments with morpholino-resistant mRNA

• Dose optimization:

  • Establish dose-response relationships to identify specific effects

  • Use the minimum effective concentration to minimize off-target effects

  • Titrate recombinant proteins when used in overexpression studies

• Experimental validation:

  • Confirm knockdown efficiency at protein level

  • Use specific inhibitors alongside genetic approaches

  • Employ multiple independent methods to confirm phenotypes

• Pathway specificity:

  • Examine effects on known downstream targets

  • Use pathway-specific inhibitors to distinguish between parallel signaling cascades

  • Compare phenotypes with those resulting from manipulation of other pathway components

What are the critical factors for successful phenotypic rescue experiments using recombinant igf1r?

Phenotypic rescue experiments are powerful tools for demonstrating specificity in igf1r functional studies. Key factors for successful rescue include:

• Timing considerations:

  • Introduce rescue constructs at appropriate developmental stages

  • Consider temporal requirements for protein expression and folding

  • Account for developmental windows when igf1r function is critical

• Expression level control:

  • Titrate rescue construct amounts to achieve physiological levels

  • Use inducible expression systems when applicable

  • Monitor protein expression levels via Western blot or fluorescent tags

• Construct design:

  • Generate morpholino-resistant constructs by introducing silent mutations

  • Consider using species orthologs for cross-species rescue

  • Create domain-specific constructs to map functional requirements

• Assessment criteria:

  • Establish quantitative metrics for rescue evaluation

  • Analyze both morphological and molecular markers of rescue

  • Document partial rescue effects when complete rescue is not achieved

How can differential phosphorylation patterns of igf1r be analyzed in developmental contexts?

Analyzing differential phosphorylation patterns of igf1r during development requires sophisticated approaches:

• Phosphoproteomics:

  • Mass spectrometry-based identification of phosphorylated residues

  • Enrichment of phosphopeptides using titanium dioxide or IMAC

  • Temporal profiling of phosphorylation changes during development

  • Quantitative comparison between developmental stages

• Phospho-specific antibodies:

  • Use antibodies targeting specific phosphorylated residues (e.g., Y1316)

  • Apply immunohistochemistry to visualize spatial distribution of activated receptors

  • Perform Western blotting for temporal profiling of activation

  • Consider generating Xenopus-specific phospho-antibodies if cross-reactivity is insufficient

• Mutational analysis:

  • Generate phosphomimetic (Y→D/E) or phospho-dead (Y→F) mutants

  • Express mutants in igf1r-depleted embryos to assess functional consequences

  • Compare signaling outcomes between different phosphorylation states

• Computational modeling:

  • Predict consequences of differential phosphorylation

  • Model pathway activation dynamics based on phosphorylation patterns

  • Compare Xenopus igf1r phosphorylation with mammalian counterparts

What techniques can be used to investigate the interaction between igf1r and IRS-1 during Xenopus eye development?

To investigate the specific interaction between igf1r and IRS-1 during Xenopus eye development, researchers can employ the following techniques:

• Protein-protein interaction analysis:

  • Co-immunoprecipitation from embryonic eye tissue

  • Proximity ligation assay for in situ detection of interactions

  • FRET or BiFC for live imaging of interactions

  • Pull-down assays using recombinant proteins

• Domain mapping:

  • Generate truncation mutants to identify interaction domains

  • Use peptide competition assays to disrupt specific interactions

  • Create point mutations in key residues to disrupt binding

• Developmental profiling:

  • Temporal analysis of complex formation during eye development

  • Spatial mapping of interaction sites using tissue-specific extracts

  • Correlation of interaction strength with developmental milestones

• Functional consequences:

  • Assess downstream signaling after disrupting the interaction

  • Examine eye development markers (Rx1, Pax6) when interaction is perturbed

  • Measure proliferation rates in contexts of normal vs. disrupted interaction

How might CRISPR/Cas9 technology enhance studies of igf1r function in Xenopus laevis?

CRISPR/Cas9 genome editing presents significant opportunities for advancing igf1r research in Xenopus laevis:

• Targeted genomic modifications:

  • Generate precise knockouts of igf1r

  • Create specific point mutations to study structure-function relationships

  • Introduce reporter tags at endogenous loci for live imaging

  • Generate conditional alleles for temporal control of gene function

• Methodological considerations for Xenopus:

  • Account for allotetraploidy of X. laevis when designing guide RNAs

  • Target both S and L homeologs for complete gene inactivation

  • Consider F0 mosaic analysis for rapid phenotypic screening

  • Establish stable lines for consistent experimental models

• Combinatorial approaches:

  • Simultaneous editing of multiple pathway components

  • Create cellular contexts for structure-function studies

  • Generate tissue-specific knockouts using tissue-specific promoters

• Advantages over traditional methods:

  • More specific than morpholinos with fewer off-target effects

  • Permanent genetic modifications versus transient knockdown

  • Ability to study later developmental stages not accessible to morpholinos

  • Possibility to create allelic series for dosage studies

What role might igf1r play in regenerative processes in Xenopus, and how can this be studied?

Xenopus laevis has significant regenerative capabilities, particularly during tadpole stages, providing opportunities to investigate igf1r's role in regeneration:

• Experimental models for regeneration studies:

  • Tail regeneration in tadpoles

  • Limb bud regeneration

  • Eye and retinal regeneration

  • Neural regeneration after injury

• Investigation approaches:

  • Temporal expression profiling of igf1r during regenerative processes

  • Spatial mapping of activated (phosphorylated) igf1r in regenerating tissues

  • Manipulation of igf1r activity using small molecule inhibitors during regeneration

  • Genetic approaches (CRISPR, morpholinos) to alter igf1r function in regenerating tissues

• Cellular mechanisms to examine:

  • Proliferation of progenitor cells in regenerating tissue

  • Cell survival and anti-apoptotic effects

  • Cell migration and patterning during regeneration

  • Dedifferentiation and transdifferentiation processes

• Comparative analysis:

  • Differences in igf1r activity between regeneration-competent and regeneration-incompetent stages

  • Cross-species comparison with mammalian models lacking equivalent regenerative capacity

  • Correlation between igf1r activity and regenerative potential across tissues